Literature DB >> 21588642

2-(3-Oxo-3,4-dihydro-2H-1,4-benzothia-zin-4-yl)acetohydrazide.

Azher Saeed, Zaid Mahmood, Shiyao Yang, Saeed Ahmad, Muhammad Salim.   

Abstract

In the title compound, C(10)H(11)N(3)O(2)S, the thia-zine ring exists in a conformation inter-mediate between twist-boat and half-chair. The dihedral angle between the mean plane of the thia-zine ring and the hydrazide group is 89.45 (13)°. In the crystal, N-H⋯O hydrogen bonds link the mol-ecules into (100) sheets and weak C-H⋯O inter-actions further consolidate the packing.

Entities:  

Year:  2010        PMID: 21588642      PMCID: PMC3008126          DOI: 10.1107/S1600536810031272

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological and medicinal activity of 1,4-benzothia­zine compounds, see: Armenise et al. (1991 ▶); Gupta et al. (1993 ▶); Vicente et al. (2009 ▶); Schiaffella et al. (2006 ▶); Kaneko et al. (2002 ▶). For the pharmacological properties of hydrazones and their derivatives, see: Sivasankar et al. (1995 ▶); Satyanarayana et al. (2008 ▶). For hydrogen-bond motifs, see: Bernstein et al. (1995 ▶).

Experimental

Crystal data

C10H11N3O2S M = 237.28 Monoclinic, a = 15.3744 (10) Å b = 7.5162 (5) Å c = 9.6256 (7) Å β = 95.413 (3)° V = 1107.35 (13) Å3 Z = 4 Mo Kα radiation μ = 0.28 mm−1 T = 296 K 0.46 × 0.23 × 0.20 mm

Data collection

Bruker Kappa APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2007 ▶) T min = 0.882, T max = 0.946 6103 measured reflections 2168 independent reflections 2077 reflections with I > 2σ(I) R int = 0.021

Refinement

R[F 2 > 2σ(F 2)] = 0.027 wR(F 2) = 0.076 S = 1.04 2168 reflections 157 parameters 2 restraints H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.18 e Å−3 Δρmin = −0.14 e Å−3 Absolute structure: Flack (1983 ▶), 792 Friedel pairs Flack parameter: 0.00 (7) Data collection: APEX2 (Bruker, 2007 ▶); cell refinement: SAINT (Bruker, 2007 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 (Farrugia, 1997 ▶) and PLATON (Spek, 2009 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶) and PLATON. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536810031272/hb5598sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810031272/hb5598Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H11N3O2SF(000) = 496
Mr = 237.28Dx = 1.423 Mg m3
Monoclinic, CcMelting point: 430 K
Hall symbol: C -2ycMo Kα radiation, λ = 0.71073 Å
a = 15.3744 (10) ÅCell parameters from 4206 reflections
b = 7.5162 (5) Åθ = 3.0–31.2°
c = 9.6256 (7) ŵ = 0.28 mm1
β = 95.413 (3)°T = 296 K
V = 1107.35 (13) Å3Needle, colorless
Z = 40.46 × 0.23 × 0.20 mm
Bruker Kappa APEXII CCD diffractometer2168 independent reflections
Radiation source: fine-focus sealed tube2077 reflections with I > 2σ(I)
graphiteRint = 0.021
φ and ω scansθmax = 28.4°, θmin = 2.7°
Absorption correction: multi-scan (SADABS; Bruker, 2007)h = −12→20
Tmin = 0.882, Tmax = 0.946k = −8→10
6103 measured reflectionsl = −12→10
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.027H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.076w = 1/[σ2(Fo2) + (0.0437P)2 + 0.2667P] where P = (Fo2 + 2Fc2)/3
S = 1.04(Δ/σ)max < 0.001
2168 reflectionsΔρmax = 0.18 e Å3
157 parametersΔρmin = −0.14 e Å3
2 restraintsAbsolute structure: Flack (1983), 792 Friedel pairs
Primary atom site location: structure-invariant direct methodsFlack parameter: 0.00 (7)
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C10.81283 (13)0.1402 (3)0.4407 (2)0.0444 (4)
C20.88393 (15)0.1642 (4)0.3624 (3)0.0684 (7)
H20.90610.06740.31700.082*
C30.92138 (15)0.3276 (5)0.3514 (3)0.0727 (7)
H30.96910.34120.29980.087*
C40.88855 (14)0.4717 (4)0.4166 (3)0.0621 (6)
H40.91450.58270.40990.074*
C50.81688 (12)0.4524 (2)0.4924 (2)0.0451 (4)
H50.79440.55140.53470.054*
C60.77806 (10)0.2868 (2)0.50596 (15)0.0325 (3)
C70.64582 (13)0.1320 (2)0.56774 (18)0.0393 (4)
C80.65696 (13)−0.0005 (2)0.4532 (2)0.0473 (4)
H8A0.63980.05370.36330.057*
H8B0.6194−0.10240.46380.057*
C90.68864 (12)0.3985 (2)0.69169 (16)0.0371 (4)
H9A0.74190.46380.71900.044*
H9B0.67100.33880.77380.044*
C100.61760 (11)0.52828 (19)0.63748 (15)0.0311 (3)
N10.70588 (9)0.26545 (17)0.58681 (13)0.0328 (3)
N20.57596 (11)0.60513 (19)0.73773 (16)0.0391 (3)
N30.50598 (12)0.7263 (3)0.70912 (19)0.0491 (4)
O10.60169 (9)0.56431 (16)0.51324 (12)0.0441 (3)
O20.58443 (11)0.1213 (2)0.63853 (16)0.0602 (4)
S10.76839 (4)−0.07275 (6)0.45907 (6)0.06435 (19)
H1N0.5831 (14)0.561 (3)0.822 (3)0.036 (5)*
H2N0.4722 (19)0.678 (4)0.641 (3)0.072 (9)*
H3N0.5321 (18)0.834 (4)0.681 (3)0.065 (8)*
U11U22U33U12U13U23
C10.0391 (9)0.0492 (9)0.0446 (10)0.0071 (7)0.0020 (8)−0.0098 (8)
C20.0384 (11)0.108 (2)0.0598 (13)0.0113 (12)0.0099 (10)−0.0256 (14)
C30.0360 (10)0.126 (2)0.0580 (14)−0.0063 (14)0.0133 (9)0.0076 (15)
C40.0409 (10)0.0773 (15)0.0673 (14)−0.0139 (10)0.0019 (10)0.0272 (12)
C50.0411 (10)0.0407 (9)0.0531 (12)−0.0021 (8)0.0022 (8)0.0107 (8)
C60.0334 (8)0.0347 (7)0.0288 (8)0.0042 (6)0.0004 (6)0.0033 (6)
C70.0462 (10)0.0359 (8)0.0360 (9)−0.0013 (7)0.0057 (7)0.0027 (7)
C80.0532 (11)0.0358 (9)0.0529 (11)−0.0081 (7)0.0049 (8)−0.0080 (7)
C90.0463 (9)0.0382 (8)0.0266 (8)0.0068 (7)0.0026 (7)−0.0034 (6)
C100.0391 (8)0.0292 (7)0.0253 (7)−0.0012 (6)0.0052 (6)−0.0015 (5)
N10.0393 (7)0.0293 (6)0.0304 (7)0.0025 (5)0.0068 (6)−0.0012 (5)
N20.0516 (9)0.0405 (7)0.0261 (7)0.0102 (6)0.0081 (6)0.0003 (6)
N30.0518 (10)0.0517 (10)0.0455 (9)0.0147 (8)0.0134 (8)0.0016 (8)
O10.0585 (8)0.0504 (7)0.0239 (6)0.0137 (6)0.0059 (5)0.0007 (5)
O20.0559 (9)0.0728 (9)0.0553 (9)−0.0161 (7)0.0223 (7)−0.0008 (8)
S10.0661 (3)0.0354 (2)0.0898 (4)0.0116 (2)−0.0018 (3)−0.0191 (3)
C1—C21.397 (3)C7—C81.508 (3)
C1—C61.400 (2)C8—S11.793 (2)
C1—S11.756 (2)C8—H8A0.9700
C2—C31.364 (4)C8—H8B0.9700
C2—H20.9300C9—N11.463 (2)
C3—C41.372 (4)C9—C101.520 (2)
C3—H30.9300C9—H9A0.9700
C4—C51.385 (3)C9—H9B0.9700
C4—H40.9300C10—O11.228 (2)
C5—C61.392 (2)C10—N21.338 (2)
C5—H50.9300N2—N31.417 (2)
C6—N11.423 (2)N2—H1N0.87 (2)
C7—O21.218 (2)N3—H2N0.87 (3)
C7—N11.364 (2)N3—H3N0.96 (3)
C2—C1—C6119.5 (2)S1—C8—H8A109.5
C2—C1—S1120.28 (17)C7—C8—H8B109.5
C6—C1—S1120.24 (15)S1—C8—H8B109.5
C3—C2—C1121.0 (2)H8A—C8—H8B108.1
C3—C2—H2119.5N1—C9—C10111.90 (13)
C1—C2—H2119.5N1—C9—H9A109.2
C2—C3—C4119.9 (2)C10—C9—H9A109.2
C2—C3—H3120.0N1—C9—H9B109.2
C4—C3—H3120.0C10—C9—H9B109.2
C3—C4—C5120.3 (2)H9A—C9—H9B107.9
C3—C4—H4119.9O1—C10—N2122.83 (15)
C5—C4—H4119.9O1—C10—C9123.14 (14)
C4—C5—C6120.8 (2)N2—C10—C9113.99 (13)
C4—C5—H5119.6C7—N1—C6124.21 (13)
C6—C5—H5119.6C7—N1—C9115.53 (14)
C5—C6—C1118.46 (16)C6—N1—C9120.12 (13)
C5—C6—N1121.03 (15)C10—N2—N3122.91 (15)
C1—C6—N1120.49 (15)C10—N2—H1N118.4 (13)
O2—C7—N1121.60 (17)N3—N2—H1N117.0 (14)
O2—C7—C8120.86 (17)N2—N3—H2N105.3 (19)
N1—C7—C8117.53 (15)N2—N3—H3N105.6 (16)
C7—C8—S1110.54 (14)H2N—N3—H3N112 (2)
C7—C8—H8A109.5C1—S1—C895.78 (9)
C6—C1—C2—C31.6 (3)O2—C7—N1—C6−178.88 (18)
S1—C1—C2—C3−177.5 (2)C8—C7—N1—C6−0.2 (2)
C1—C2—C3—C4−0.8 (4)O2—C7—N1—C9−3.3 (2)
C2—C3—C4—C5−0.7 (4)C8—C7—N1—C9175.45 (16)
C3—C4—C5—C61.2 (3)C5—C6—N1—C7155.73 (17)
C4—C5—C6—C1−0.3 (3)C1—C6—N1—C7−25.7 (2)
C4—C5—C6—N1178.29 (17)C5—C6—N1—C9−19.7 (2)
C2—C1—C6—C5−1.1 (3)C1—C6—N1—C9158.89 (15)
S1—C1—C6—C5178.02 (14)C10—C9—N1—C7−76.87 (18)
C2—C1—C6—N1−179.71 (19)C10—C9—N1—C698.95 (17)
S1—C1—C6—N1−0.6 (2)O1—C10—N2—N34.2 (3)
O2—C7—C8—S1−135.26 (18)C9—C10—N2—N3−178.15 (17)
N1—C7—C8—S146.0 (2)C2—C1—S1—C8−143.10 (19)
N1—C9—C10—O1−26.9 (2)C6—C1—S1—C837.80 (16)
N1—C9—C10—N2155.47 (14)C7—C8—S1—C1−58.15 (15)
D—H···AD—HH···AD···AD—H···A
N3—H3N···O2i0.96 (3)2.35 (3)3.299 (3)171 (2)
N2—H1N···O1ii0.87 (2)2.07 (2)2.935 (2)175.5 (18)
C3—H3···O2iii0.932.483.406 (3)174
C8—H8B···O1iv0.972.573.442 (2)150
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N3—H3N⋯O2i0.96 (3)2.35 (3)3.299 (3)171 (2)
N2—H1N⋯O1ii0.87 (2)2.07 (2)2.935 (2)175.5 (18)
C3—H3⋯O2iii0.932.483.406 (3)174
C8—H8B⋯O1iv0.972.573.442 (2)150

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) .

  7 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Anticancer activities of 2,3-dihydro-1,4-benzothiazines, and of their 4-(N-alkyl amides) and 4-(N-alkyl N-nitrosoamides).

Authors:  R R Gupta; P K Dev; M L Sharma; C M Rajoria; A Gupta; M Nyati
Journal:  Anticancer Drugs       Date:  1993-10       Impact factor: 2.248

3.  Novel ketoconazole analogues based on the replacement of 2,4-dichlorophenyl group with 1,4-benzothiazine moiety: design, synthesis, and microbiological evaluation.

Authors:  Fausto Schiaffella; Antonio Macchiarulo; Lara Milanese; Anna Vecchiarelli; Renata Fringuelli
Journal:  Bioorg Med Chem       Date:  2006-05-02       Impact factor: 3.641

4.  Inhibitors of adhesion molecules expression; the synthesis and pharmacological properties of 10H-pyrazino[2,3-b][1,4]benzothiazine derivatives.

Authors:  Toshihiko Kaneko; Richard S J Clark; Norihito Ohi; Tetsuya Kawahara; Hiroshi Akamatsu; Fumihiro Ozaki; Atsushi Kamada; Kazuo Okano; Hiromitsu Yokohama; Kenzo Muramoto; Masayoshi Ohkuro; Osamu Takenaka; Seiichi Kobayashi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2002-07       Impact factor: 1.645

5.  Preparation of potentially bioactive aza and thiaza polycyclic compounds containing a bridgehead nitrogen atom synthesis and antimicrobial activity of some pyrrolo[1,2,3-de]-1,4-benzothiazines.

Authors:  D Armenise; G Trapani; V Arrivo; F Morlacchi
Journal:  Farmaco       Date:  1991-09

6.  Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acids.

Authors:  Javier de Vicente; Robert T Hendricks; David B Smith; Jay B Fell; John Fischer; Stacey R Spencer; Peter J Stengel; Peter Mohr; John E Robinson; James F Blake; Ramona K Hilgenkamp; Calvin Yee; Junping Zhao; Todd R Elworthy; Jahari Tracy; Elbert Chin; Jim Li; Al Lui; Beihan Wang; Connie Oshiro; Seth F Harris; Manjiri Ghate; Vincent J P Leveque; Isabel Najera; Sophie Le Pogam; Sonal Rajyaguru; Gloria Ao-Ieong; Ludmila Alexandrova; Bill Fitch; Michael Brandl; Mohammad Masjedizadeh; Shao-Yong Wu; Steve de Keczer; Tatyana Voronin
Journal:  Bioorg Med Chem Lett       Date:  2009-08-08       Impact factor: 2.823

7.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  7 in total
  4 in total

1.  Crystal structure of (E)-2-benzyl-idene-4-[(3-phenyl-4,5-di-hydro-isoxazol-5-yl)meth-yl]-2H-benzo[b][1,4]thia-zin-3(4H)-one.

Authors:  Nada Kheira Sebbar; Mohamed Ellouz; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-05-23

2.  2-(3-Oxo-3,4-dihydro-2H-1,4-benzothia-zin-4-yl)acetamide.

Authors:  Azher Saeed; Zaid Mahmood; Shiyao Yang; Muhammad Salim; Muhammad Saleem Akhtar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-15

3.  Methyl 2-(3-oxo-3,4-dihydro-2H-1,4-benzothia-zin-4-yl)acetate.

Authors:  Yamna Barryala; Stéphane Massip; Saïd Lazar; El Mokhtar Essassi; Hafid Zouihri
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-02-26

4.  (2Z)-2-Benzyl-idene-4-n-butyl-3,4-di-hydro-2H-1,4-benzo-thia-zin-3-one.

Authors:  Nada Kheira Sebbar; Mohammed El Fal; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.